Researchers from Universite de Montreal (Canada) and Manchester University (UK) have published a systematic review of studies describing IL-1 blockade in pregnancy. The review combines […]
Welcome
ENTIS is a global collaborative network of Teratology Information Services. Member organisations consist of medical doctors, pharmacists, genetic counsellors and scientists all working together with the primary aim of preventing birth defects and developmental disorders which arise as a consequence of maternal or paternal perinatal exposures.
ENTIS member organisations work in three core areas:
ENTIS collaborates with researchers from a range of academic, industry and patient representative organisations. If you are interested in working with ENTIS or in joining our network, please contact us.
Alternatively, click here to learn more about ENTIS.
Latest Annual Conference News
For more details about the 33rd annual ENTIS conference, click here.
Latest Teratology Studies
No evidence for an increased risk of malformation or miscarriage following ciprofloxacin use in early pregnancy
Researchers from the Department of Clinical Pharmacology at Copenhagen University Hospital have published a nationwide register-based cohort study investigating the safety of early pregnancy ciprofloxacin […]
Is there an optimal method for assessing fetal growth parameters?
Researchers have published their findings from a study into the ability of two international birthweight standards (customised GROW and INTERGROWTH-21st) to identify perinatal morbidity and […]
Interim results from the Biogen Multiple Sclerosis Pregnancy Exposure Registry
Interim results have been published using data collected in the Biogen Multiple Sclerosis Pregnancy Exposure Registry. This latest study provides safety data for oral delayed-release […]
Large population-based study of duloxetine use in pregnancy published
Researchers from the University of Copenhagen and Copenhagen University Hospital have published a large population-based observational study investigating the safety of gestational duloxetine use. The […]
First trimester anticoagulant exposure in women with preconception venous thromboembolism
Researchers from Aalborg University have published a national cohort study investigating the risk of adverse pregnancy outcomes following first trimester anticoagulant exposure. More information can […]
Data published on the safety metopimazine use in pregnancy
Researchers from Toulouse University have utilised the EFEMERIS database (Haute-Garonne, France) to provide safety data regarding the safety of metopimazine use in pregnancy (an anti-emetic […]
New data published on the safety of hydroxychloroquine in pregnancy
Researchers from the OTIS Collaborative Research Group have conducted a prospective study of birth outcomes among 279 women who have taken hydroxycholoroquine in pregnancy. More […]